Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
61
NCT04176133
Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination
Phase: Phase 2
Role: Collaborator
Start: Oct 30, 2019
Completion: Mar 30, 2022